Last reviewed · How we verify
ketamine and bupivacaine injection
At a glance
| Generic name | ketamine and bupivacaine injection |
|---|---|
| Sponsor | Ain Shams University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Dexmedetomidine vs Ketamine as Adjuvants to Bupivacaine in Transversus Abdominus Plane Block in Inguinal Hernioplasty (PHASE3)
- Non-opioid Anesthesia Based on Thoracic Paravertebral Block During Laparoscopic Sleeve Gastrectomy (NA)
- Vital Capacity in Ultrasound Guided Serratus Plane Block in ED Patients With Multiple Rib Fractures (PHASE4)
- Fascia Iliaca Block Versus Intravenous Dexmedetomidine and Ketamine for Positioning Fracture Femur (NA)
- Dexmedetomedine and Ketamine in Erector Spinae Block for Postoperative Analgesia Following Mastectomy. (PHASE2, PHASE3)
- Adductor Canal Block in Total Knee Arthroplasty (PHASE4)
- Supraclavicular Brachial Plexus Block During Upper Limb Surgeries (EARLY_PHASE1)
- Opioid Free Anesthesia in Thoracic Surgery (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- ketamine and bupivacaine injection CI brief — competitive landscape report
- ketamine and bupivacaine injection updates RSS · CI watch RSS
- Ain Shams University portfolio CI